News

Oct 4th 2018 Collaborator, Dr. Kazuya Sakai will present data of anti-von Willerbrand Factor A1 domain Xenoligo at the American Society of Hematology

TITLE: Inhibitory Effect of a Novel DNA Aptamer with Artificial Nucleic Bases for Von Willebrand Factor A1 Domain on Platelet Thrombosis FormationAmerican Society of Hematology

the American Society of Hematology, the 60th Annual Meeting and Exposition (December 1-4, 2018) in San Diego ,
CA Session Name: 332. Anti-thrombotic Therapy: Poster II
Date: Sunday, December 2, 2018 at 6PM PDT

Authors: Kazuya Sakai1, Hideo Yagi1, Masaki Hayakawa1, Tatsuhiko
Someya2, Kaori Harada2, and Masanori Matsumoto1 1. Department of
Blood Transfusion Medicine, Nara Medical University, Nara, Japan 2.
TAGCyx Biotechnologies Inc, Tokyo, Japan

The conference information will be found here.

Comments are closed.